News from

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2793 Results
What happens to the brain after a traumatic injury?
TBI Football Research Senior Justin Morrison (left) and researcher Michael Sangobowale with Ebony Cook, a patient in for a follow-up visit after her apartment ceiling caved in on her. It’s part of an ongoing clinical trial on traumatic brain injury that sees patients five times each, at 72 hours following injury, then again at two weeks, three weeks, six months, and a year later.

What happens to the brain after a traumatic injury?

Two undergrads interning with Penn Medicine’s Ramon Diaz-Arrastia spent the summer looking for biomarkers in the blood of TBI patients, and studying whether the generic form of Viagra might help promote recovery after such an injury.

Michele W. Berger

Teachers become students to become better teachers at GRASP Lab’s RET program
grasp_lab

The Rehabilitation Robotics Lab at Penn’s Perelman School of Medicine was one of the sites where GRASP Lab members gave local high school teachers a crash course in robotics. 

Teachers become students to become better teachers at GRASP Lab’s RET program

The Research Experiences for Teachers (RET) program run by the GRASP Lab in the School of Engineering and Applied Science is part of a larger National Science Foundation effort to get students interested in science and engineering at an early age. This summer, one cohort of students worked with robots in the Rehabilitation Robotics Lab at the Perelman School of Medicine.

Penn Today Staff

Targeting a viral vulnerability to treat disease
Ricciardi, Rob

Robert Ricciardi

Targeting a viral vulnerability to treat disease

Robert Ricciardi company ViRAZE utilizes interdisciplinary approaches to drug discovery. Its first target is molluscum contagiosum, a disease that targets children and immune-compromised adults with no current FDA-approved therapy.

Katherine Unger Baillie

Finding patterns in a class of neurological disorders
als

Finding patterns in a class of neurological disorders

Research from Penn Engineering and the Perelman School of Medicine has found that the shared pattern is misfolded in Fragile X Syndrome, a member of the class of disorders that also includes ALS and Huntington’s disease

Penn Today Staff

Stigmatizing views and myths about psoriasis are pervasive
psoriasis

Stigmatizing views and myths about psoriasis are pervasive

New multidisciplinary research involving both psychologists and dermatologists from the Perelman School of Medicine is the first to examine how common this stigma may be among the general population of the United States.

Penn Today Staff

An oasis of compassion
Mary Walton, Director of the Family Caregiver Center

Mary Walton, director of the Family Caregiver Center, led the effort to establish the Center in 2015.

An oasis of compassion

Since 2015, the Hospital of the University of Pennsylvania has supported the Family Caregiver Center, a three-room space that serves an array of needs, from resources to relaxation, for caregivers—one of only a few in the United States.
CAR T cell therapy receives approval for use across European Union
car t flash mob

Folks from the Abramson Cancer Center celebrate Kymriah’s initial approval by the U.S. Food and Drug Administration in August 2017.

CAR T cell therapy receives approval for use across European Union

The European Commission has approved a personalized cellular therapy developed at the Abramson Cancer Center, making it the first CAR T cell therapy permitted for use in the European Union in two distinct indications.

Penn Today Staff

New insights into malaria culprit
malaria

Photo courtesy of NIAID

New insights into malaria culprit

New insights from the Perelman School of Medicine on the origins of deadly infectious diseases are vital to understanding the emergence of human pathogens, and may even lead to eradicating malaria.

Penn Today Staff